ClinicalTrials.Veeva

Menu

Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

The Washington University logo

The Washington University

Status

Begins enrollment this month

Conditions

Cancer of the Lung
Lung Cancer

Treatments

Other: Pink and Pearl Campaign

Study type

Interventional

Funder types

Other

Identifiers

NCT07146568
202508075

Details and patient eligibility

About

Inspired by the ongoing Pink & Pearl Campaign, the breast radiology service of Christian Hospital in north St. Louis County will partner with Siteman Cancer Center to pilot this campaign in its mammography clinics in order to promote awareness, referral, and completion of lung cancer screening (LCS) among eligible women. This campaign leverages established infrastructure such as nurse navigation and referral to screening or primary care for further shared decision-making on cancer screening. The purpose of this study is to evaluate the effectiveness of the Pink & Pearl Campaign in improving LCS uptake among LCS-eligible women undergoing mammography at Christian Hospital. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, our specific aims for this proposal are to: a) assess whether the Pink & Pearl Campaign increases referrals and uptake/completion of LCS among LCS-eligible women undergoing screening mammography; b) determine median time-to-screening after referral to LCS; and c) evaluate individual and health system factors influencing LCS uptake and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.

Enrollment

5,515 estimated patients

Sex

All

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Eligibility Criteria - Interventional Study

  • Undergoing screening mammography at Christian Hospital
  • Between the ages of 50-80 years (inclusive)

Eligibility Criteria - Survey and Interview Sub-Studies

  • Part of the interventional study
  • Reporting a 20 pack-year equivalent of either current smoking history or have quit in the past 15 years
  • Can speak and understand English
  • Not diagnosed with a serious health problem that will limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year)
  • Willing and able to get treatment if lung cancer is found
  • Able to understand and willing to sign an IRB-approved written informed consent document

Eligibility Criteria - Providers

  • At least 20 years of age
  • Involved in the breast radiology service or referred at least one patient to the Pink & Pearl Campaign
  • Able to provide verbal consent to participate in the interview

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

5,515 participants in 2 patient groups

Participants - scheduled for mammography and eligible for LCS
Experimental group
Description:
All women coming in for breast cancer screening will be assessed for LCS eligibility using a screening questionnaire administered by mammography technicians. Patients who are determined to be eligible for LCS will be asked by the mammography technician if they will opt into being contacted by the nurse navigator, who will facilitate their referral to primary care to schedule a LCS appointment at Siteman Cancer Center.
Treatment:
Other: Pink and Pearl Campaign
Providers
No Intervention group
Description:
Providers in the breast radiology service who referred women to LCS. Investigators will gather information on the feasibility, acceptability, and appropriateness of the Pink and Pearl project.

Trial contacts and locations

1

Loading...

Central trial contact

Beryne Odeny, M.D., MPH, Ph.D.; Michelle V Lee, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems